Q1 2024 Holdings
Filed 2024-05-15 | 39 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $196.3M | 4,360,000 | 13.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $136.5M | 3,165,000 | 9.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $111.7M | 1,487,756 | 7.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $93.3M | 2,167,793 | 6.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $71.5M | 1,884,084 | 4.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $69.9M | 3,973,245 | 4.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $58.7M | 860,000 | 3.9% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $54.8M | 5,833,333 | 3.7% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $54.5M | 1,375,000 | 3.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $52.6M | 1,275,000 | 3.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $45.5M | 1,050,000 | 3.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $43.2M | 6,425,000 | 2.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $39.9M | 1,725,000 | 2.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $36.4M | 866,468 | 2.4% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $34.2M | 3,165,000 | 2.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $33.9M | 1,934,653 | 2.3% |
| Celcuity Inc(CELC) | COM | 15102K100 | $33.6M | 1,555,954 | 2.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $32.5M | 1,525,000 | 2.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $27.9M | 3,410,384 | 1.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $27.5M | 2,000,000 | 1.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $27.1M | 1,895,003 | 1.8% |
| Perspective Therapeutics Inc | COM | 46489V104 | $25.1M | 21,052,631 | 1.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $24.3M | 750,990 | 1.6% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $22.7M | 912,189 | 1.5% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $21.2M | 1,250,000 | 1.4% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $19.3M | 290,000 | 1.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $18.8M | 1,100,000 | 1.3% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $14.7M | 2,300,000 | 1.0% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $11.8M | 1,250,000 | 0.8% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $10.2M | 200,000 | 0.7% |
| Adverum Biotechnologies Inc(AVU0) | COM NEW | 00773U207 | $9.3M | 657,333 | 0.6% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $8.3M | 1,575,000 | 0.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.6M | 318,851 | 0.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $7.3M | 169,533 | 0.5% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.2M | 500,000 | 0.3% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $4.3M | 295,020 | 0.3% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $3.2M | 1,374,320 | 0.2% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $831.6K | 183,174 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $69.4K | 92,687 | 0.0% |